UK National Screening Committee
Featured
The National Institute for Health and Care Research has advertised the research call for the in-service evaluation of newborn screening for spinal muscular atrophy.
The UK NSC this summer plans to share its review of the latest evidence on whether women with dense breasts should be offered additional breast screening imaging tests.
We are asking stakeholders to provide feedback on an evidence summary and its conclusions relating to newborn screening for metachromatic leukodystrophy (MLD).
A review of data from 2013 to 2023 has found that AAA screening in the UK has been effective and has contributed substantially to ongoing reductions in AAA-related deaths.
The National Institute for Health Research is investing millions of pounds to provide the UK NSC with dedicated research expertise.
April is Bowel Cancer Awareness Month, which is a good time to highlight evidence and data that clearly demonstrates the effectiveness of bowel cancer screening.
Latest from the UK National Screening Committee
What we do
The UK National Screening Committee (UK NSC) advises ministers and the NHS in the 4 UK countries about all aspects of screening and supports implementation of screening programmes.
UK NSC is part of the Department of Health and Social Care, the Welsh Government, The Scottish Government, and the Department of Health (Northern Ireland).
Follow us
Documents
Transparency and freedom of information releases
Our management
Contact UK NSC
UK National Screening Committee
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of information (FOI) requests
Department of Health and Social Care 39 Victoria Street
London
SW1H 0EU
United Kingdom
Corporate information
Jobs and contracts
Our Personal information charter explains how we treat your personal information. Read our policy on Social media use.